Lipitor, Atorvastatin

Lipitor, Atorvastatin Newswire

Comprehensive Real-Time News Feed for Lipitor, Atorvastatin (generic).

Results 1 - 20 of 895 in Lipitor, Atorvastatin (generic)

  1. Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP ReportsRead the original story w/Photo

    14 hrs ago | PRWeb

    Well over 1,000 claims have been filed in the Lipitor diabetes litigation since it was established this past February. Lipitor lawsuits that have been filed on behalf of patients who allegedly developed Type 2 diabetes due to its use continue to move forward in the federal multidistrict litigation now underway in U.S. District Court, District of South Carolina, Bernstein Liebhard LLP reports.

    Comment?

  2. A green transformation for pharmaceuticalsRead the original story w/Photo

    Friday | Science Daily

    A more sustainable approach to a bond-forming reaction extensively used in the pharmaceutical and fine chemical industries has now been developed. The team used the solvent-free, catalytic reaction to produce high yields of a wide range of amides, including the antidepressant moclobemide and other drug-like molecules.

    Comment?

  3. RPT-New data fuels doctors' demands to rewrite U.S. heart guidelinesRead the original story

    Friday | Reuters

    Controversial heart disease prevention guidelines that abandoned specific targets for reducing "bad" LDL cholesterol are under fresh assault after a major study highlighted the benefits of taking LDL to very low levels. Guidelines issued last year by the American Heart Association and the American College of Cardiology asked doctors to assess individual patients' risk for heart disease over 10 years based on a complex calculation of risks posed by lifestyle, family history and other health conditions.

    Comment?

  4. Do The IMPROVE-IT Results Offer Promise For Another Merck Heart Drug - Anacetrapib?Read the original story w/Photo

    Friday | Forbes.com

    I was the president of Pfizer Global Research and Development in 2007 where I managed more than 13,000 scientists and professionals in the United States, Europe, and Asia. I've received numerous awards including an Honorary Doctor of Science degree from the University of New Hampshire.

    Comment?

  5. Results announced from six Phase 3 trials showing that alirocumab...Read the original story w/Photo

    Friday | Medical News Today

    Sanofi and Regeneron Pharmaceuticals, Inc. has announced new detailed positive results from six Phase 3 ODYSSEY trials that showed alirocumab significantly reduced low-density lipoprotein cholesterol . Alirocumab is an investigational fully human monoclonal antibody targeting the protein PCSK9 that is being evaluated for its ability to lower LDL-C.

    Comment?

  6. New data fuels doctors' demands to rewrite U.S. heart guidelinesRead the original story

    Thursday | Reuters

    Controversial heart disease prevention guidelines that abandoned specific targets for reducing "bad" LDL cholesterol are under fresh assault after a major study highlighted the benefits of taking LDL to very low levels. Guidelines issued last year by the American Heart Association and the American College of Cardiology asked doctors to assess individual patients' risk for heart disease over 10 years based on a complex calculation of risks posed by lifestyle, family history and other health conditions.

    Comment?

  7. Early statin use may give long-term heart benefitsRead the original story w/Photo

    Thursday Nov 20 | WZVN-TV Fort Myers

    A shooting at a home in a secluded wooded area of southern New Jersey left two children dead and a woman believed to be their mother and the children's brother critically wounded, state police said Thursday. A grand jury looking into a deadly Florida jail explosion says there isn't enough evidence to bring criminal charges.

    Comment?

  8. Do cholesterol-lowering statins live up to the hype?Read the original story w/Photo

    Thursday Nov 20 | Bangor Daily News

    As a doctor of chiropractic, I do not prescribe drugs. However, I am trained to look for side effects in my patients who take them.

    Comment?

  9. For Healthcare I Want The Republican Plan - Get Sick and DieRead the original story w/Photo

    Thursday Nov 20 | Daily Kos

    First, the Corporate Personhood puts Trans Fat in all our foods. Then the Pharmaceutical Personhood prescribes Lipitor to counter the Trans Fat negatives in your body.

    Comment?

  10. Using statin early can help heart for decades to comeRead the original story w/Photo

    Thursday Nov 20 | The Times-Tribune

    Taking a cholesterol-lowering drug for five years in middle age can lower heart and death risks for decades afterward, and the benefits seem to grow over time, a landmark study finds. Doctors say it's the first evidence that early use of a statin can have a legacy effect, perhaps changing someone's odds of disease for good.

    Comment?

  11. Amarin riding high on new study resultsRead the original story w/Photo

    Thursday Nov 20 | The Day

    Interest in the stock of Amarin Corp. plc shot up this week with the surprise announcement that its lead heart drug, Vascepa, showed remarkable power for reducing cholesterol particles in the bloodstream. On Tuesday, Amarin was one of the hottest stocks on the Nasdaq exchange, rising more than 23 percent.

    Comment?

  12. Use of cholesterol drug in middle age lowers heart risks for decades later, study findsRead the original story w/Photo

    Wednesday Nov 19 | Canada.com

    Taking a cholesterol-lowering drug for five years in middle age can lower heart and death risks for decades afterward, and the benefits seem to grow over time, a landmark study finds. Doctors say it's the first evidence that early use of a statin can have a legacy effect, perhaps changing someone's odds of disease for good.

    Comment?

  13. 10 Things to Know for ThursdayRead the original story w/Photo

    Wednesday Nov 19 | The Charlotte Observer

    This June 14, 2011, file photo, shows the drug Lipitor at Medco Health Solutions Inc., in Willingboro, N.J. A new study shows very long-term benefits from even short-term use of cholesterol-lowering statin drugs, such as Lipitor. FILE - In this March 2, 2014 file photo, Bono arrives at the Oscars at the Dolby Theatre in Los Angeles.

    Comment?

  14. Lipitor Lawsuit News: More Than 1,400 Diabetes Claims Now Pending in...Read the original story w/Photo

    Wednesday Nov 19 | PRWeb

    The Firm is evaluating Lipitor lawsuits on behalf of patients who developed Type 2 diabetes, allegedly due to their use of the statin medication. More than two years after federal regulators warned of this potential risk, Lipitor patients who allegedly developed diabetes because of this medication continue to contact our Firm on a regular basis.

    Comment?

  15. Will The IMPROVE-IT Results Impact The Thinking Of The FDA And Payers ...Read the original story w/Photo

    Wednesday Nov 19 | Forbes.com

    I was the president of Pfizer Global Research and Development in 2007 where I managed more than 13,000 scientists and professionals in the United States, Europe, and Asia. I've received numerous awards including an Honorary Doctor of Science degree from the University of New Hampshire.

    Comment?

  16. Alirocumab Reduces LDL Cholesterol in Six Phase III TrialsRead the original story

    Wednesday Nov 19 | P&T Community

    Positive results have been reported from six phase III studies of alirocumab , an investigational fully human monoclonal antibody targeting the protein PCSK9 that is being evaluated for its ability to reduce low-density lipoprotein cholesterol , or "bad" cholesterol. All of the trials -- ODYSSEY LONG TERM, COMBO I, ALTERNATIVE, OPTIONS I, OPTIONS II, and HIGH FH -- met their primary efficacy endpoint of a greater reduction in LDL-C at 24 weeks versus either an active comparator or placebo, which included standard-of-care therapy.

    Comment?

  17. Study lifts cloud over new cholesterol drugsRead the original story w/Photo

    Tuesday Nov 18 | SouthCoastToday.com

    A major study lifts a cloud around Zetia and Vytorin, blockbuster drugs for lowering cholesterol. The study found that these pills modestly lower the risk of heart attacks and other problems in people at high risk for them - evidence that's been missing for more than a decade as the drugs racked up billions in sales.

    Comment?

  18. Regeneron and Sanofi Announce New Results from Six Phase 3 Trials...Read the original story

    Wednesday Nov 19 | Applied Clinical Trials

    Alirocumab is an investigational fully human monoclonal antibody targeting the protein PCSK9 that is being evaluated for its ability to lower LDL-C. All six trials, ODYSSEY LONG TERM, COMBO I, ALTERNATIVE, OPTIONS I, OPTIONS II, and HIGH FH, met their primary efficacy endpoint of a greater reduction in LDL-C at 24 weeks, versus either active comparator or placebo, which included standard-of-care therapy.

    Comment?

  19. Experimental Cholesterol-Lowering Drug Effective, Study ReportsRead the original story w/Photo

    Tuesday Nov 18 | MedicineNet

    An experimental antibody drug could prove effective at lowering LDL cholesterol levels for patients who have side effects with cholesterol-lowering statin medications. The drug, alirocumab, outperformed the on-the-market medication that is currently the most widely used alternative to statins , Zetia, said lead researcher Dr. Patrick Moriarty, director of clinical pharmacology at the University of Kansas Medical Center.

    Comment?

  20. Study Lifts Cloud Over Heart Drugs Zetia, VytorinRead the original story w/Photo

    Tuesday Nov 18 | Pharmaceutical Processing

    A major study lifts a cloud around Zetia and Vytorin, blockbuster drugs for lowering cholesterol. The study found that these pills modestly lower the risk of heart attacks and other problems in people at high risk for them - evidence that's been missing for more than a decade as the drugs racked up billions in sales.

    Comment?